Sep. 9, 2009 (Business Wire) -- Law Offices of Howard G. Smith announces that it is investigating potential claims against the board of directors of Candela Corporation (“Candela” or the “Company”) (Nasdaq:CLZR) related to the Company’s merger agreement with Syneron Medical Ltd. (“Syneron”), in an all-stock transaction valued at approximately $65 million.

Under the terms of the definitive agreement entered into by the parties, Candela shareholders will receive 0.2911 ordinary shares of Syneron for each share of Candela common stock they own. Based on the closing price of Syneron common stock on September 8, 2009, the transaction value is approximately $2.84 per Candela share. The investigation concerns possible breaches of fiduciary duty and other violations of state law related to approval of the transaction by the Candela board of directors.

If you own shares of Candela Corporation, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com.